AT-007 in Adult Subjects With Classic Galactosemia (CG)

Clinical trial NCT05418829 · UNKNOWN

Trial details

NCT number: NCT05418829
Sponsor: Applied Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Classic Galactosemia

Start date: 2021-10-01
Primary completion: 2022-11-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.